leadf
logo-loader
viewPhagelux

Phagelux looking to raise $20M for its Phase 1 and Phase 2 studies

Phagelux CEO Mark Engel sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The privately-held, China-based company utilizes phages to solve bacterial problems in multiple fields including crop diseases, animal health, food safety and general sanitary. 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Cabral Gold adds 2nd drill rig as company identifies new high-grade veins

Cabral Gold (CVE: CBR-OTC: CBGZF) CEO Alan Carter joined Steve Darling from Proactive Vancouver with news the company has identified at least six new NE trending high-grade veins in the Machichie SW area located immediately north of the MG deposit. Carter telling Proactive what had led them...

1 day, 12 hours ago

2 min read